Thirty points for sure

The generic name — tofacitinib — is not exactly euphonious either. But Xeljanz? Huh? Nancy Friedman? Anyone?

Oh, and Pfizer thinks highly of this stuff: it’s two grand a month. Wholesale. No credit for knowing that the pill was originally developed by a guy from the National Institutes of Health.







3 comments

  1. Brian J. »

    15 October 2013 · 10:08 am

    Using all seven tiles constitutes a bingo, which is fifty points plus the value of the tiles.

    Of course, that particular set of letters would be hard to play off of an existing game board. But I’m guessing they’re all starting from the first play of the game when naming pharmaceuticals.

  2. Joseph Hertzlinger »

    19 October 2013 · 9:46 pm

    If you object to someone making a profit you could try starting up a pharmaceutical equivalent of GNU or Linux.

  3. CGHill »

    19 October 2013 · 9:56 pm

    Well, we already know how much regard the government has for open-source.

RSS feed for comments on this post